Click for best price

Molecular Diagnostics Infectious Disease Testing Market Size, Share 2022

Market Analysis and Insights: Global Molecular Diagnostics Infectious Disease Testing Market

The global Molecular Diagnostics Infectious Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Infectious Disease Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Infectious Disease Testing market.

Global Molecular Diagnostics Infectious Disease Testing Scope and Market Size

Molecular Diagnostics Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Bacterial Infectious Disease Testing

Viral Infectious Disease Testing

Parasitic Infectious Disease Testing

Segment by Application

Hospital

Laboratory Research

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Abbott Laboratories

bioM?rieux

Thermo Fisher Scientific

F. Hoffmann-La Roche

Siemens AG

Veridex

Luminex

GenMark Diagnostics

Qiagen NV

Genomix Biotech

BioTheranostics

GenMark Diagnostics

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Molecular Diagnostics Infectious Disease Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Molecular Diagnostics Infectious Disease Testing, with price, sales, revenue, and global market share of Molecular Diagnostics Infectious Disease Testing from 2019 to 2022.

Chapter 3, the Molecular Diagnostics Infectious Disease Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Molecular Diagnostics Infectious Disease Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Molecular Diagnostics Infectious Disease Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Infectious Disease Testing.

Chapter 13, 14, and 15, to describe Molecular Diagnostics Infectious Disease Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Molecular Diagnostics Infectious Disease Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	94 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Development
11.3 bioM?rieux
11.3.1 bioM?rieux Company Detail
11.3.2 bioM?rieux Business Overview
11.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioM?rieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.3.5 bioM?rieux Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Siemens AG
11.6.1 Siemens AG Company Detail
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens AG Recent Development
11.7 Veridex
11.7.1 Veridex Company Detail
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Development
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Detail
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Development
11.10 Qiagen NV
11.10.1 Qiagen NV Company Detail
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen NV Recent Development
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Detail
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Development
11.12 BioTheranostics
11.12.1 BioTheranostics Company Detail
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Development
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Detail
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.13.5 GenMark Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Bacterial Infectious Disease Testing
Table 3. Key Players of Viral Infectious Disease Testing
Table 4. Key Players of Parasitic Infectious Disease Testing
Table 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region (2023-2028)
Table 11. Molecular Diagnostics Infectious Disease Testing Market Trends
Table 12. Molecular Diagnostics Infectious Disease Testing Market Drivers
Table 13. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 14. Molecular Diagnostics Infectious Disease Testing Market Restraints
Table 15. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players (2017-2022)
Table 17. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Table 18. Ranking of Global Top Molecular Diagnostics Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 26. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2017-2022)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Application (2023-2028)
Table 32. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abbott Laboratories Company Detail
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product
Table 45. Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 46. Abbott Laboratories Recent Development
Table 47. BD Company Detail
Table 48. BD Business Overview
Table 49. BD Molecular Diagnostics Infectious Disease Testing Product
Table 50. BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 51. BD Recent Development
Table 52. bioM?rieux Company Detail
Table 53. bioM?rieux Business Overview
Table 54. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product
Table 55. bioM?rieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 56. bioM?rieux Recent Development
Table 57. Thermo Fisher Scientific Company Detail
Table 58. Thermo Fisher Scientific Business Overview
Table 59. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product
Table 60. Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 61. Thermo Fisher Scientific Recent Development
Table 62. F. Hoffmann-La Roche Company Detail
Table 63. F. Hoffmann-La Roche Business Overview
Table 64. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product
Table 65. F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. Siemens AG Company Detail
Table 68. Siemens AG Business Overview
Table 69. Siemens AG Molecular Diagnostics Infectious Disease Testing Product
Table 70. Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 71. Siemens AG Recent Development
Table 72. Veridex Company Detail
Table 73. Veridex Business Overview
Table 74. Veridex Molecular Diagnostics Infectious Disease Testing Product
Table 75. Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 76. Veridex Recent Development
Table 77. Luminex Company Detail
Table 78. Luminex Business Overview
Table 79. Luminex Molecular Diagnostics Infectious Disease Testing Product
Table 80. Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 81. Luminex Recent Development
Table 82. GenMark Diagnostics Company Detail
Table 83. GenMark Diagnostics Business Overview
Table 84. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product
Table 85. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 86. GenMark Diagnostics Recent Development
Table 87. Qiagen NV Company Detail
Table 88. Qiagen NV Business Overview
Table 89. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product
Table 90. Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 91. Qiagen NV Recent Development
Table 92. Genomix Biotech Company Detail
Table 93. Genomix Biotech Business Overview
Table 94. Genomix Biotech Molecular Diagnostics Infectious Disease TestingProduct
Table 95. Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 96. Genomix Biotech Recent Development
Table 97. BioTheranostics Company Detail
Table 98. BioTheranostics Business Overview
Table 99. BioTheranostics Molecular Diagnostics Infectious Disease TestingProduct
Table 100. BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 101. BioTheranostics Recent Development
Table 102. GenMark Diagnostics Company Detail
Table 103. GenMark Diagnostics Business Overview
Table 104. GenMark Diagnostics Molecular Diagnostics Infectious Disease TestingProduct
Table 105. GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 106. GenMark Diagnostics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Bacterial Infectious Disease Testing Features
Figure 3. Viral Infectious Disease Testing Features
Figure 4. Parasitic Infectious Disease Testing Features
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Laboratory Research Case Studies
Figure 8. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 9. Global Molecular Diagnostics Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Molecular Diagnostics Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Market Share by Players in 2021
Figure 13. Global Top Molecular Diagnostics Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
Figure 15. North America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 17. United States Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 21. Germany Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Region (2017-2028)
Figure 29. China Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 37. Mexico Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Country (2017-2028)
Figure 41. Turkey Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 44. BD Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 45. bioM?rieux Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 48. Siemens AG Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 49. Veridex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 50. Luminex Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 51. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 52. Qiagen NV Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 53. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 54. BioTheranostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 55. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2022